These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 33830479)

  • 1. Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?
    Kelty E; Terplan M; Greenland M; Preen D
    Drugs; 2021 May; 81(7):739-748. PubMed ID: 33830479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
    Kranzler HR; Soyka M
    JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.
    Rolland B; Paille F; Gillet C; Rigaud A; Moirand R; Dano C; Dematteis M; Mann K; Aubin HJ
    CNS Neurosci Ther; 2016 Jan; 22(1):25-37. PubMed ID: 26768685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.
    Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
    Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pharmacotherapies for alcohol dependence.
    Graham R; Wodak AD; Whelan G
    Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-Based Pharmacotherapies for Alcohol Use Disorder: Clinical Pearls.
    Fairbanks J; Umbreit A; Kolla BP; Karpyak VM; Schneekloth TD; Loukianova LL; Sinha S
    Mayo Clin Proc; 2020 Sep; 95(9):1964-1977. PubMed ID: 32446635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
    Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
    Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAEM GRACE: Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence.
    Punia K; Scott W; Manuja K; Sabbineni M; Campbell K; Balodis IM; MacKillop J
    Acad Emerg Med; 2024 May; 31(5):504-514. PubMed ID: 37735346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder.
    Belnap MA; McManus KR; Grodin EN; Ray LA
    Pharmaceut Med; 2024 Jul; 38(4):291-302. PubMed ID: 38967906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapies and personalized medicine for alcohol use disorder: a review.
    Lohoff FW
    Pharmacogenomics; 2020 Oct; 21(15):1117-1138. PubMed ID: 32807012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of healthcare utilization among patients treated with alcoholism medications.
    Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
    Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden.
    Månsson A; Danielsson AK; Sjöqvist H; Glatz T; Lundin A; Wallhed Finn S
    Addict Sci Clin Pract; 2024 May; 19(1):41. PubMed ID: 38764075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Petrov I; Krogh J; Nordentoft M
    Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
    Williams EC; Matson TE; Harris AHS
    Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.
    Burnette EM; Nieto SJ; Grodin EN; Meredith LR; Hurley B; Miotto K; Gillis AJ; Ray LA
    Drugs; 2022 Feb; 82(3):251-274. PubMed ID: 35133639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
    Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological interventions for alcohol misuse in correctional settings: A systematic review.
    Slavin-Stewart C; Minhas M; Turna J; Brasch J; Olagunju AT; Chaimowitz G; MacKillop J
    Alcohol Clin Exp Res; 2022 Jan; 46(1):13-24. PubMed ID: 34825363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Safety of Alcohol Pharmacotherapies in Pregnancy: A Scoping Review of Human and Animal Research.
    Quintrell E; Russell DJ; Rahmannia S; Wyrwoll CS; Larcombe A; Kelty E
    CNS Drugs; 2024 Oct; ():. PubMed ID: 39388037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.
    Chaignot C; Zureik M; Rey G; Dray-Spira R; Coste J; Weill A
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1239-1248. PubMed ID: 30251424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.